National Post: FDA lashes out at drug company for promoting Canadian morning-sickness pill on Kardashian Instagram feed

Professor Timothy Caulfield comments on the FDA's response to a Canadian drug company over its part in an unusual intersection of celebrity culture, social media and pharmaceutical marketing. An Instagram post by Kim Kardashian extolling the benefits of the firm's morning-sickness drug was false or misleading and "misbranded" the pills, said the U.S. Food and Drug Administration in a warning letter disclosed Tuesday. Story also appears in Calgary Herald and Ottawa Citizen.

12 August 2015